Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: suberoylanilide hydroxamic acid (SAHA, Vorinostat)|DRUG: tamoxifen citrate (Tamoxifen)
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Merck Sharp & Dohme LLC